Agranulocytosis Salvarsanny

Salvarsan agranulocytosis is a rare disease characterized by a sharp decrease in the number of leukocytes in the blood. In this case, the decrease in the number of white blood cells is associated with the use of the drug Salvarsan, which is used to treat tuberculosis.

Salvarsan is a drug from the sulfonamide group that is used to treat infectious diseases such as tuberculosis and brucellosis. It was developed in the early 20th century, and is still used in some countries to treat these diseases.

However, the use of salvarsan can lead to agranulocytosis, a condition when the number of white blood cells in the blood decreases to zero. This can lead to serious complications such as infections, sepsis and even death.

Symptoms of salvarsan agranulocytosis may include fever, weakness, decreased appetite, bone and joint pain, and frequent infections. If you notice these symptoms, you should contact your doctor immediately.

Treatment for salvarsan agranulocytosis involves stopping salvarsan and giving antibiotics to fight the infection. You may also need a blood transfusion to restore your white blood cell count.

Agranulocytosis is a serious disease that can be caused by various reasons. However, if you are taking salvarsan to treat tuberculosis, you should be aware of the possible risks and take precautions to avoid agranulocytosis.